MDWD
Mediwound Ltd
13.30$
-0.7%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -26.1% | -31.9% | +23.4% | -20.1% | +15.1% | -23.5% | -36.5% | +153.3% | +32.9% | +10.6% | +17.4% | |
| – | -26.4% | -33.3% | +23.5% | -21.2% | +8.9% | -26.5% | -42.9% | +206.6% | +8.4% | +5.0% | +15.0% | |
| – | +67.2% | -32.1% | +25.0% | -81.4% | +7.8% | +139.9% | -36.4% | +206.9% | -65.0% | -22.8% | -47.6% | |
| – | -29.4% | -34.4% | +20.1% | -34.5% | +24.6% | -27.4% | -48.4% | +206.9% | +22.6% | +3.9% | +23.1% | |
| – | +44.5% | -5.9% | +25.4% | +111.5% | -37.4% | -37.6% | -20.2% | +327.7% | -54.4% | +32.4% | -59.5% | |
| – | +20.7% | -50.8% | +123.5% | -10.9% | -4.0% | -14.4% | -13.0% | +63.6% | +45.0% | -5.4% | +52.0% | |
| – | -4.4% | +22.7% | +50.8% | +5.0% | +124.4% | -0.4% | -10.8% | -11.1% | – | – | – | |
| – | -5.8% | -13.7% | -17.9% | -22.0% | -13.3% | -15.4% | -18.2% | -22.2% | -28.6% | -40.0% | -66.7% | |
| – | +2.8% | -3.6% | +23.3% | -23.8% | -3.4% | -6.4% | +2.2% | +60.7% | -10.8% | +21.5% | +0.7% | |
| – | +33.6% | +3.3% | +1.0% | -9.9% | +111.8% | -20.3% | +29.7% | +12.5% | -10.2% | +145.1% | -3.1% | |
| – | +52.2% | -49.5% | +5.9% | – | – | -44.2% | +0.5% | -82.7% | -32.1% | +15.8% | +49.0% | |
| – | -7.5% | +29.7% | +123.3% | -16.5% | +49.8% | -26.4% | +56.9% | +20.5% | -25.3% | -3.0% | -11.9% | |
| – | +4.2% | -6.0% | +7.9% | – | – | – | – | – | – | – | – | |
| – | -45.3% | -66.9% | +23.8% | -6.7% | +69.1% | -52.1% | -163.0% | – | +189.5% | -1.4% | +40.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +9.1% | +0.9% | +6.8% | +16.2% | +0.3% | +0.1% | +0.1% | +28.1% | +80.7% | +10.5% | +14.2% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.